Hepatic resection beyond barcelona clinic liver cancer indication: When and how

Area of Science:

• Hepatology
• Surgical Oncology
• Gastroenterology

Background:

• Hepatocellular carcinoma (HCC) is a primary liver tumor often linked to cirrhosis.
• Current Barcelona Clinic Liver Cancer (BCLC) guidelines restrict hepatic resection to early-stage HCC.
• Emerging evidence suggests potential benefits of resection for advanced HCC cases.

Purpose of the Study:

• To evaluate liver resection indications for hepatocellular carcinoma (HCC) beyond current BCLC guidelines.
• To explore strategies for optimizing surgical outcomes in HCC patients with cirrhosis.
• To review the role of multidisciplinary teams, intraoperative ultrasound, and laparoscopy in HCC resection.

Main Methods:

• Literature review analyzing studies on liver resection for HCC.
• Discussion of the BCLC classification and its limitations.
• Emphasis on multidisciplinary decision-making and advanced surgical techniques.

Main Results:

• The BCLC classification's restrictive approach to liver resection for HCC is debated.
• Studies indicate that patients with larger tumors, multiple lesions, or portal hypertension may benefit from resection.
• Multidisciplinary approaches, intraoperative ultrasound, and laparoscopic surgery can improve outcomes.

Conclusions:

• Liver resection may be indicated for a broader range of HCC patients, including those with intermediate/advanced stages if technically resectable.
• Balancing oncological radicality with minimizing organ damage is crucial in HCC surgery on cirrhosis.
• A multidisciplinary approach and advanced surgical techniques are key to successful HCC resection beyond current guidelines.